Individual Institutional Fintech & Developer
Sign in
Open account
Individuals Institutional

Call toll-free 800.328.1267

Login

Market Insights

Opportunity knocks for those with trading in their DNA.
Curiosity creates opportunity. Insights create strategy. Born traders create their destiny.

Stocks

Options

Futures

Healthcare | Stocks | Technical Analysis
Have Biotechs Broken Their Downtrend?
David Russell
June 4, 2025

Biotechnology stocks have struggled this year along with the broader health-care sector, but some traders may think a bullish turn has begun.

The first pattern on today’s chart of the Nasdaq Biotechnology Index is the series of lower highs since early April. NBI closed above that falling trendline yesterday, which may signal …

For more, please click here to view the related idea and chart analysis on TradingView.

Nasdaq Biotechnology Index, daily chart, with selected patterns and indicators, courtesy of TradingView.

Tags:

About the author

David Russell
David Russell is Global Head of Market Strategy at TradeStation. Drawing on more than two decades of experience as a financial journalist and analyst, his background includes equities, emerging markets, fixed-income and derivatives. He previously worked at Bloomberg News, CNBC and E*TRADE Financial. Russell systematically reviews countless global financial headlines and indicators in search of broad tradable trends that present opportunities repeatedly over time. Customers can expect him to keep them apprised of sector leadership, relative strength and the big stories – especially those overlooked by other commentators. He’s also a big fan of generating leverage with options to limit capital at risk.

Related stories